6535
順藥
-2.80 (-3.58%)75.40228成交張數–本益比10.20股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 14 | 12 | 9.0% | 6.47 | 7.38 | -25.9% | -23.7% | -1.2 | – |
| 2026Q1 | 15 | 14 | 8.1% | 7.37 | 8.31 | -22.2% | -19.9% | -0.5 | – |
| 2025Q4 | 17 | 15 | 7.9% | 7.37 | 8.94 | -19.9% | -18.0% | -0.4 | -0.4 |
| 2025Q3 | 17 | 16 | 7.5% | 7.91 | 9.43 | -31.6% | -27.9% | -0.5 | -0.5 |
| 2025Q2 | 18 | 16 | 7.0% | 10.00 | 9.58 | -42.1% | -37.5% | -1.9 | – |
| 2025Q1 | 21 | 18 | 11.0% | 6.60 | 10.74 | -26.6% | -23.1% | -0.8 | – |
| 2024Q4 | 21 | 19 | 9.6% | 7.64 | 11.32 | -25.7% | -22.4% | -1.0 | -1.0 |
| 2024Q3 | 14 | 12 | 14.6% | 3.74 | 7.00 | -29.2% | -25.0% | -0.5 | -0.5 |
| 2024Q2 | 16 | 14 | 12.8% | 4.09 | 8.29 | -18.8% | -16.3% | -0.6 | – |
| 2024Q1 | 15 | 13 | 13.2% | 4.45 | 7.84 | -32.5% | -28.3% | -0.8 | – |
| 2023Q4 | 17 | 14 | 13.8% | 4.75 | 8.49 | -15.7% | -13.4% | -0.7 | -0.8 |
| 2023Q3 | 17 | 15 | 11.0% | 5.88 | 9.25 | -5.5% | -4.9% | -0.6 | -0.8 |
| 2023Q2 | 19 | 16 | 10.4% | 6.24 | 9.97 | -7.2% | -6.3% | -1.1 | – |
| 2023Q1 | 20 | 18 | 9.6% | 6.75 | 10.89 | -8.9% | -8.0% | -0.8 | – |
| 2022Q4 | 19 | 16 | 11.4% | 6.44 | 9.99 | -26.4% | -23.4% | -0.4 | -0.4 |
| 2022Q3 | 18 | 16 | 11.1% | 6.97 | 9.74 | -46.6% | -42.0% | -1.0 | -1.0 |
| 2022Q2 | 20 | 17 | 10.8% | 7.02 | 10.68 | -14.1% | -12.6% | -0.9 | -0.9 |
| 2022Q1 | 21 | 19 | 9.5% | 7.79 | 11.86 | -8.5% | -7.6% | -0.7 | -0.7 |
| 2021Q4 | 23 | 21 | 9.8% | 7.23 | 12.98 | 5.2% | 4.6% | -1.8 | -1.8 |
| 2021Q3 | 23 | 21 | 8.7% | 7.58 | 13.89 | 23.2% | 20.4% | -0.8 | -0.8 |
| 2021Q2 | 18 | 16 | 10.9% | 8.20 | 10.86 | -14.2% | -12.1% | -1.0 | -1.0 |
| 2021Q1 | 20 | 18 | 11.1% | 8.13 | 11.61 | -10.7% | -9.0% | -0.9 | -0.9 |
| 2020Q4 | 18 | 16 | 11.3% | 7.07 | 10.74 | -24.5% | -20.8% | -0.8 | -0.8 |
| 2020Q3 | 10 | 8 | 19.5% | 3.30 | 6.89 | -34.2% | -29.1% | -1.0 | -1.0 |
| 2020Q2 | 11 | 9 | 20.3% | 3.45 | 7.29 | -35.1% | -30.0% | -0.9 | -0.9 |
| 2020Q1 | 12 | 9 | 22.5% | 3.20 | 7.95 | -25.4% | -21.3% | 1.5 | 1.5 |
| 2019Q4 | 13 | 10 | 21.0% | 3.52 | 8.90 | -20.8% | -17.7% | -2.2 | -2.2 |
| 2019Q3 | 13 | 11 | 10.9% | 6.45 | 9.71 | -14.8% | -13.1% | -0.7 | -0.7 |
| 2019Q2 | 14 | 12 | 9.8% | 7.32 | 10.38 | -7.2% | -6.5% | -0.5 | – |
| 2019Q1 | 13 | 12 | 10.9% | 7.07 | 10.26 | -11.9% | -10.7% | -0.4 | – |
| 2018Q4 | 14 | 13 | 8.7% | 7.91 | 10.93 | -5.1% | -4.6% | 0.1 | 0.0 |
| 2018Q3 | 8 | 7 | 13.1% | 7.54 | 6.99 | -15.5% | -13.5% | -0.3 | -0.3 |
| 2018Q2 | 8 | 7 | 9.5% | 10.34 | 7.10 | -20.0% | -18.1% | -0.2 | -0.2 |
| 2018Q1 | 8 | 7 | 9.1% | 10.77 | 7.41 | -23.8% | -21.9% | -0.4 | -0.4 |
| 2017Q4 | 8 | 7 | 14.5% | 6.78 | 7.25 | -27.2% | -24.6% | -0.1 | -0.1 |
| 2017Q3 | 8 | 7 | 12.9% | 7.62 | 7.70 | – | – | -0.3 | -0.3 |
| 2017Q2 | 9 | 8 | 9.7% | 10.07 | 8.19 | – | – | -0.0 | -0.1 |
| 2017Q1 | 9 | 8 | 7.1% | 13.42 | 8.83 | – | – | -0.3 | -0.3 |